Selected research
Industry Research
Oligonucleotide Array Industry Research Report 2026
Market perspective
The global Oligonucleotide Array market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Oligonucleotide Array is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Oligonucleotide Array is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Oligonucleotide Array is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Oligonucleotide Array include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Oligonucleotide Array market in revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Oligonucleotide Array.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oligonucleotide Array Market by Company
Illumnia
Affymetrix
Agilent Technologies
Roche NimbleGen
Sengenics
Arrayit
Applied Microarrays
Biometrix Technology
Savyon Diagnostics
Scienion AG
WaferGen
Oligonucleotide Array Segment by Type
Long Oligonucleotide Chip
Short Oligonucleotide Chip
Oligonucleotide Array Segment by Application
Gene Expression
Genotyping
Others
Oligonucleotide Array Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oligonucleotide Array market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oligonucleotide Array and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oligonucleotide Array.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oligonucleotide Array manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oligonucleotide Array by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oligonucleotide Array in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Long Oligonucleotide Chip
- Short Oligonucleotide Chip
Applications
- Gene Expression
- Genotyping
- Others
Companies covered
- Illumnia
- Affymetrix
- Agilent Technologies
- Roche NimbleGen
- Sengenics
- Arrayit
- Applied Microarrays
- Biometrix Technology
- Savyon Diagnostics
- Scienion AG
- WaferGen
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Oligonucleotide Array by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Long Oligonucleotide Chip
- 2.2.3 Short Oligonucleotide Chip
- 2.3 Oligonucleotide Array by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Gene Expression
- 2.3.3 Genotyping
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Oligonucleotide Array Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Oligonucleotide Array Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Oligonucleotide Array Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Oligonucleotide Array Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Oligonucleotide Array Production by Manufacturers (2021-2026)
- 3.2 Global Oligonucleotide Array Production Value by Manufacturers (2021-2026)
- 3.3 Global Oligonucleotide Array Average Price by Manufacturers (2021-2026)
- 3.4 Global Oligonucleotide Array Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Oligonucleotide Array Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Oligonucleotide Array Manufacturers, Product Type & Application
- 3.7 Global Oligonucleotide Array Manufacturers Established Date
- 3.8 Global Oligonucleotide Array Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Illumnia
- 4.1.1 Illumnia Oligonucleotide Array Company Information
- 4.1.2 Illumnia Oligonucleotide Array Business Overview
- 4.1.3 Illumnia Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 4.1.4 Illumnia Product Portfolio
- 4.1.5 Illumnia Recent Developments
- 4.2 Affymetrix
- 4.2.1 Affymetrix Oligonucleotide Array Company Information
- 4.2.2 Affymetrix Oligonucleotide Array Business Overview
- 4.2.3 Affymetrix Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 4.2.4 Affymetrix Product Portfolio
- 4.2.5 Affymetrix Recent Developments
- 4.3 Agilent Technologies
- 4.3.1 Agilent Technologies Oligonucleotide Array Company Information
- 4.3.2 Agilent Technologies Oligonucleotide Array Business Overview
- 4.3.3 Agilent Technologies Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 4.3.4 Agilent Technologies Product Portfolio
- 4.3.5 Agilent Technologies Recent Developments
- 4.4 Roche NimbleGen
- 4.4.1 Roche NimbleGen Oligonucleotide Array Company Information
- 4.4.2 Roche NimbleGen Oligonucleotide Array Business Overview
- 4.4.3 Roche NimbleGen Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 4.4.4 Roche NimbleGen Product Portfolio
- 4.4.5 Roche NimbleGen Recent Developments
- 4.5 Sengenics
- 4.5.1 Sengenics Oligonucleotide Array Company Information
- 4.5.2 Sengenics Oligonucleotide Array Business Overview
- 4.5.3 Sengenics Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 4.5.4 Sengenics Product Portfolio
- 4.5.5 Sengenics Recent Developments
- 4.6 Arrayit
- 4.6.1 Arrayit Oligonucleotide Array Company Information
- 4.6.2 Arrayit Oligonucleotide Array Business Overview
- 4.6.3 Arrayit Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 4.6.4 Arrayit Product Portfolio
- 4.6.5 Arrayit Recent Developments
- 4.7 Applied Microarrays
- 4.7.1 Applied Microarrays Oligonucleotide Array Company Information
- 4.7.2 Applied Microarrays Oligonucleotide Array Business Overview
- 4.7.3 Applied Microarrays Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 4.7.4 Applied Microarrays Product Portfolio
- 4.7.5 Applied Microarrays Recent Developments
- 4.8 Biometrix Technology
- 4.8.1 Biometrix Technology Oligonucleotide Array Company Information
- 4.8.2 Biometrix Technology Oligonucleotide Array Business Overview
- 4.8.3 Biometrix Technology Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 4.8.4 Biometrix Technology Product Portfolio
- 4.8.5 Biometrix Technology Recent Developments
- 4.9 Savyon Diagnostics
- 4.9.1 Savyon Diagnostics Oligonucleotide Array Company Information
- 4.9.2 Savyon Diagnostics Oligonucleotide Array Business Overview
- 4.9.3 Savyon Diagnostics Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 4.9.4 Savyon Diagnostics Product Portfolio
- 4.9.5 Savyon Diagnostics Recent Developments
- 4.10 Scienion AG
- 4.10.1 Scienion AG Oligonucleotide Array Company Information
- 4.10.2 Scienion AG Oligonucleotide Array Business Overview
- 4.10.3 Scienion AG Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 4.10.4 Scienion AG Product Portfolio
- 4.10.5 Scienion AG Recent Developments
- 4.11 WaferGen
- 4.11.1 WaferGen Oligonucleotide Array Company Information
- 4.11.2 WaferGen Oligonucleotide Array Business Overview
- 4.11.3 WaferGen Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 4.11.4 WaferGen Product Portfolio
- 4.11.5 WaferGen Recent Developments
5 Global Oligonucleotide Array Production by Region
- 5.1 Global Oligonucleotide Array Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Oligonucleotide Array Production by Region: 2021-2032
- 5.2.1 Global Oligonucleotide Array Production by Region: 2021-2026
- 5.2.2 Global Oligonucleotide Array Production Forecast by Region (2027-2032)
- 5.3 Global Oligonucleotide Array Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Oligonucleotide Array Production Value by Region: 2021-2032
- 5.4.1 Global Oligonucleotide Array Production Value by Region: 2021-2026
- 5.4.2 Global Oligonucleotide Array Production Value Forecast by Region (2027-2032)
- 5.5 Global Oligonucleotide Array Market Price Analysis by Region (2021-2026)
- 5.6 Global Oligonucleotide Array Production and Value, YOY Growth
- 5.6.1 North America Oligonucleotide Array Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Oligonucleotide Array Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Oligonucleotide Array Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Oligonucleotide Array Production Value Estimates and Forecasts (2021-2032)
- 5.6.5 South Korea Oligonucleotide Array Production Value Estimates and Forecasts (2021-2032)
6 Global Oligonucleotide Array Consumption by Region
- 6.1 Global Oligonucleotide Array Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Oligonucleotide Array Consumption by Region (2021-2032)
- 6.2.1 Global Oligonucleotide Array Consumption by Region: 2021-2026
- 6.2.2 Global Oligonucleotide Array Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Oligonucleotide Array Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Oligonucleotide Array Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Oligonucleotide Array Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Oligonucleotide Array Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Oligonucleotide Array Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Oligonucleotide Array Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Oligonucleotide Array Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Oligonucleotide Array Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Oligonucleotide Array Production by Type (2021-2032)
- 7.1.1 Global Oligonucleotide Array Production by Type (2021-2032) & (k units)
- 7.1.2 Global Oligonucleotide Array Production Market Share by Type (2021-2032)
- 7.2 Global Oligonucleotide Array Production Value by Type (2021-2032)
- 7.2.1 Global Oligonucleotide Array Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Oligonucleotide Array Production Value Market Share by Type (2021-2032)
- 7.3 Global Oligonucleotide Array Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Oligonucleotide Array Production by Application (2021-2032)
- 8.1.1 Global Oligonucleotide Array Production by Application (2021-2032) & (k units)
- 8.1.2 Global Oligonucleotide Array Production Market Share by Application (2021-2032)
- 8.2 Global Oligonucleotide Array Production Value by Application (2021-2032)
- 8.2.1 Global Oligonucleotide Array Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Oligonucleotide Array Production Value Market Share by Application (2021-2032)
- 8.3 Global Oligonucleotide Array Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Oligonucleotide Array Value Chain Analysis
- 9.1.1 Oligonucleotide Array Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Oligonucleotide Array Production Mode & Process
- 9.2 Oligonucleotide Array Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Oligonucleotide Array Distributors
- 9.2.3 Oligonucleotide Array Customers
10 Global Oligonucleotide Array Analyzing Market Dynamics
- 10.1 Oligonucleotide Array Industry Trends
- 10.2 Oligonucleotide Array Industry Drivers
- 10.3 Oligonucleotide Array Industry Opportunities and Challenges
- 10.4 Oligonucleotide Array Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst